CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that it has been added to the Russell 2000 ®, Russell 3000 ®, and Russell Microcap ® Indexes, effective after the U.S.